Bank of Nova Scotia increased its Pfizer share stake by 42.4% in Q4, bringing holdings to $225.71m.
Bank of Nova Scotia increased its stake in Pfizer by 2,336,209 shares during the fourth quarter, bringing its total holdings to 7,840,192 shares, worth $225.71 million. This marks a 42.4% increase in the bank's holdings. Other institutional investors, including Norges Bank, Charles Schwab Investment Management Inc., and Morgan Stanley, have also recently modified their holdings of Pfizer shares.
June 01, 2024
6 Articles